Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Cargill, Evolva Move On Biotech Stevia
by Melody M. Bomgardner
September 16, 2013
| A version of this story appeared in
Volume 91, Issue 37
Cargill and Evolva, a Swiss biotech firm, say their development program for making steviol glycosides from fermentation will move to pilot scale this year rather than in 2014. Steviol glycosides are sweet-tasting molecules produced by the stevia plant and used in low-calorie foods and beverages (see page 11). Cargill markets Truvia, the first mass-produced stevia-based sweetener. The fermentation route will enable cost-effective production of the most desirable glycosides, which occur naturally in small amounts in the stevia plant, according to the companies.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter